Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Becoming the best at Discussion: Individual Procedures - 2France, Germany, Italy summon Iranian envoys over 'unbearable, inhumane' regime crackdown
- 3The Best Web-based Courses for Expertise Improvement
- 4At least 490 protesters killed in Iran, activists say
- 5Fake new headlights rule steer Australian drivers astray
- Magnetic fossils may reveal ancient creature's internal 'GPS system'
- Investigate These Retreats Well known With Seniors
- Audits of Espresso Types: Which Mix Is for You?
- Novo and Lilly cut prices of weight-loss drugs in China
- 7 Popular Vacation destinations In China
- Moderna to complete US mRNA manufacturing network with $140 million investment
- Barn Stored Lotus Esprit Turbo Seen After 30 Years
- AI is making spacecraft propulsion more efficient – and could even lead to nuclear-powered rockets
- Tire Brands for Senior Drivers: Guaranteeing Security and Solace
